Interestingly, non-CpG methylation of PGC1-α was increased by tumor necrosis factor (TNF)-α or free fatty acids, which can be elevated in the metabolic syndrome and NAFLD. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.